Concepedia

David J. Wustrow

DJ

39

Publications

2.2K

Citations

25

H-Index

1985

Active since

Affiliations

Pfizer (United States)(Current)

Rapt Therapeutics (United States)

APT Therapeutics (United States)

Gaertner (United States)

University of Groningen

David J. Wustrow is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1985–2023

39

Publications

39

Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis

Daniel J. Anderson, Ronan Le Moigne, Stevan Djakovic et al. · Cancer Cell · 2015 · 392 citations · Full text

, , +13

Isoindolinone enantiomers having affinity for the dopamine D4 receptor

Thomas R. Belliotti, Wouter A. Brink, Suzanne R. Kesten et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 209 citations · Full text

, , +5

Structure−Activity Relationships of Pregabalin and Analogues That Target the α<sub>2</sub>-δ Protein

Thomas R. Belliotti, Thomas Capiris, I. Victor Ekhato et al. · Journal of Medicinal Chemistry · 2005 · 208 citations

, , +19

Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083)

Han-Jie Zhou, Jinhai Wang, Bing Yao et al. · Journal of Medicinal Chemistry · 2015 · 184 citations · Full text

, , +20

Tumors establish resistance to immunotherapy by regulating T<sub>reg</sub>recruitment via CCR4

Lisa A. Marshall, Sachie Marubayashi, Aparna Jorapur et al. · Journal for ImmunoTherapy of Cancer · 2020 · 131 citations · Full text

Rows per page

1–5 of 39